What is the cause of gastrointestinal (GI) bleeding from a stomach neurofibroma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Gastrointestinal bleeding from a stomach neurofibroma is typically caused by ulceration or erosion of the tumor into blood vessels within the gastric mucosa, leading to bleeding. The management of gastrointestinal bleeding from a stomach neurofibroma requires a multidisciplinary approach, prioritizing stabilization of the patient through intravenous fluids, blood transfusions if necessary, and acid suppression therapy using proton pump inhibitors, such as pantoprazole 40mg IV twice daily or omeprazole 40mg IV twice daily 1.

Key Considerations

  • Endoscopic evaluation is essential for diagnosis and may allow for endoscopic interventions like epinephrine injection, thermal coagulation, or clip placement to control active bleeding.
  • For definitive management, surgical resection of the neurofibroma is often necessary, with the approach (partial gastrectomy, wedge resection, or endoscopic submucosal dissection) depending on the size, location, and extent of the tumor.
  • Neurofibromas are benign tumors arising from the nerve sheath, and those occurring in the stomach are rare but can be associated with neurofibromatosis type 1 (NF1).

Treatment Approach

  • The initial management focuses on resuscitation, maintenance of hemodynamic stability, and triage (in-patient versus intensive care unit care), as outlined in the recent American College of Gastroenterology practice guidelines and an American Gastroenterological Association expert statement 1.
  • Esophagogastroduodenoscopy is the usual first-line diagnostic and therapeutic investigation, with video capsule endoscopy sometimes used if the bleeding site is suspected to be below the ligament of Treitz 1.
  • High-dose intravenous proton-pump inhibition is recommended in patients who have undergone successful endoscopic therapy, as suggested by consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding 1.

Follow-up Care

  • Following treatment, patients should undergo surveillance endoscopy at intervals determined by their gastroenterologist.
  • Those with NF1 require comprehensive follow-up for monitoring of other potential manifestations of the disease.

From the Research

Causes of Gastrointestinal (GI) Bleeding from a Stomach Neurofibroma

  • The cause of GI bleeding from a stomach neurofibroma can be attributed to the tumor's potential to erode the mucosal lining, leading to bleeding 2.
  • Neurofibromas of the stomach can occur in the course of Recklinghausen's disease, and sporadic gastric neurofibroma can also cause bleeding from the gastrointestinal tract 3.
  • The tumor may look like an ulcer and can be a cause of abdominal pain, nausea, and bleeding from the gastrointestinal tract 3.
  • Massive retrogastric bleeding can be caused by a neurofibroma arising from the gastric wall 2.

Associated Conditions and Symptoms

  • Neurofibromas are associated with Recklinghausen's disease, also known as type 1 Neurofibromatosis (NF1) 4, 3.
  • Patients with NF1 are at a higher risk of developing gastrointestinal stromal tumors (GISTs), which can also cause GI bleeding 4.
  • Symptoms of GI bleeding from a stomach neurofibroma can include hematemesis, melena, and hematochezia 4, 5.

Diagnosis and Treatment

  • Diagnosis of a stomach neurofibroma can be challenging and may require a combination of endoscopic ultrasound, computed tomography, and histopathological examination with immunohistochemistry 3.
  • Treatment of a stomach neurofibroma typically involves excision of the tumor, which can be performed laparoscopically 4, 3.
  • Endoscopic management of GI bleeding from a non-variceal source, such as a stomach neurofibroma, can include injection, thermal, and mechanical methods 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Non-variceal Upper Gastrointestinal Bleeding and Its Endoscopic Management.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2024

Related Questions

What is the main differential diagnosis and next steps for a 22-year-old male presenting with less than 24 hours of emesis (vomiting) and diarrhea, accompanied by a cough and sore throat, with initial episodes of bright red blood in emesis but no subsequent hematemesis (vomiting blood) or coffee ground emesis?
What is the next step in assessing an elderly female patient with maroon colored stool, tachypnea, pallor, hypotension, and tachycardia?
What is the most appropriate next step in managing a patient with hypotension, tachycardia, and melena, taking ibuprofen, with lab results showing anemia and normal platelet count?
What is the most appropriate next step in managing a patient with hypotension, tachycardia, and severe anemia presenting with melena and dizziness?
What is the most helpful initial test for a middle-aged female with severe abdominal pain relieved by morphine and an episode of hematemesis?
What is the interpretation of nerve conduction studies (NCS) in diagnosing neurological disorders?
What is Ludwig's angina (a severe infection of the submandibular space)?
What are the implications of elevated total insulin and C-peptide (Connecting Peptide) levels?
Are there contraindications to using cetirizine (Zytec) or loratadine (Claritin) in a patient taking hydrochlorothiazide (hydrochloride)?
What is the treatment for deep vein thrombosis (DVT) of the lower limb with anticoagulants?
What treatment for onychomycosis in a patient with impaired renal function (eGFR: estimated Glomerular Filtration Rate) of 41?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.